Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinpi Tongfeng Fang
- Development stage
- Unknown
- Lead developer
- Sichuan New Green Pharmaceutical Technology
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qinpi Tongfeng Fang (秦皮痛风方) is a traditional Chinese medicine (TCM) formula developed for the treatment of acute gouty arthritis. The formula is based on classical TCM principles and modern pharmacological research, with its main ingredient being Cortex Fraxini (Qinpi), which has demonstrated anti-inflammatory, analgesic, uric acid-lowering, and diuretic effects. Clinical studies indicate that Qinpi Tongfeng Fang can reduce joint pain and swelling in acute gout attacks, lower serum uric acid levels more effectively than some conventional treatments like colchicine or diclofenac sodium sustained-release tablets, and has a lower incidence of adverse reactions compared to these chemical drugs. Its mechanism involves multiple pathways including anti-inflammation, pain relief, reduction of uric acid production, and promotion of uric acid excretion[3][4][5]. The formula typically contains several herbal components such as Cortex Fraxini (Qinpi), Smilax glabra (Tufuling), Plantago asiatica (Cheqianzi), Reynoutria japonica (Huzhang), among others[6]. It is administered orally.
- Other names
- 秦皮痛风方
02
Targets
IL8 (C-X-C Motif Chemokine Ligand 8)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)MMP9 (Matrix metalloproteinase-9)NFKBIA (NFKB inhibitor alpha)URAT1 (Uric Acid Transporter 1)
Beyond the preview
Go deeper on Qinpi Tongfeng Fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qinpi Tongfeng Fang.